MediBeat - HeartBeat Observation Trial
Primary Purpose
Low Blood Pressure, Blood Pressure, High Blood Pressure
Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Contec CMS50EW
Sphygmomanometer
Sponsored by
About this trial
This is an interventional other trial for Low Blood Pressure
Eligibility Criteria
Inclusion Criteria:
- adult over 25 years of age
Exclusion Criteria:
- those who have heart arrhythmias,
- atrial fibrillations or atrial flutters,
- an inaudible Korotkoff sound,
- wounds of the upper arms/wrists, missing fingers, and/or
- an arm circumference of more than 55 cm will be excluded
Sites / Locations
- SE Health
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Other
Other
Other
Arm Label
Low Blood Pressure
Medium Blood Pressure
High Blood Pressure
Arm Description
Low blood pressure (systolic: 0-129, diastolic: 0-79)
Medium blood pressure (systolic: 130-160, diastolic: 80-100)
High blood pressure (systolic: 161 or higher, diastolic: 101 or higher)
Outcomes
Primary Outcome Measures
Difference Between Systolic Manual Sphygmomanometer and Finger Pulse Oximeter Readings
Each device reading was compared to the manual blood pressure reading taken before (R1) and after it (R2). The degree of alignment for systolic blood pressure was calculated by taking the difference between the two scores (manual and device). The reading with the best alignment was used.
Difference Between Diastolic Manual and Device Blood Pressure Readings
Each device reading was compared to the manual reading before (R1) and after (R2) it, to calculate the degree of alignment. The difference of the device and R1, and the device and R2 were taken. The smaller number was used for results reporting.
Secondary Outcome Measures
Full Information
NCT ID
NCT04082819
First Posted
September 4, 2019
Last Updated
March 17, 2020
Sponsor
SE Health
Collaborators
Centre for Aging and Brain Health Innovation
1. Study Identification
Unique Protocol Identification Number
NCT04082819
Brief Title
MediBeat - HeartBeat Observation Trial
Official Title
Determining the Accuracy of the HeartBeat Algorithm for Calculating Blood Pressure
Study Type
Interventional
2. Study Status
Record Verification Date
March 2020
Overall Recruitment Status
Completed
Study Start Date
October 4, 2019 (Actual)
Primary Completion Date
November 22, 2019 (Actual)
Study Completion Date
December 17, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
SE Health
Collaborators
Centre for Aging and Brain Health Innovation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
5. Study Description
Brief Summary
The goal of the study was to compare the current gold standard blood pressure instrument (a mercury-filled sphygmomanometer with cuff and stethoscope) with the new experimental algorithm developed by HeartBeat Technologies Ltd. To that end, participants were recruited from Markham, Ontario and participated in a series of alternating blood pressure measurements over a period of 45 minutes. Comparisons were made between manual measurements and device measurements to determine the quality of the device readings. Measurements were taken by trained nurses and staff were consistent across the study duration.
Detailed Description
The gold standard instrument for blood pressure measurement is a mercury-filled sphygmomanometer with cuff and stethoscope (Canadian Agency for Drugs and Technologies in Health; Canadian Electronic Library, 2012). However, such a device is not the most convenient for client self-monitoring or virtual (remote) care. Thus, there is a desire for an accurate, reliable alternative for the traditional mercury-containing sphygmomanometer.
HeartBeat Technologies Ltd. ("Heartbeat") has developed a novel approach to measuring blood pressure after an initial blood pressure reading using the conventional measurement method, supplemented by specific characteristics of a person (age, gender, height, weight, and heart rate), has established a "baseline measurement" for the person. The "novel approach" uses a finger pulse oximeter, the Contec CMS50EW device (Figure 1) (manufactured by Contec Medical Systems Co., Ltd., Shanghai, People's Republic of China). The finger pulse oximeter detects the changes in blood volume directly below the person's skin and indirectly measures oxygen saturation in the blood. The measurement is in the form of a photoplethysmogram (PPG) which is captured by the Contec oximeter and then, by Bluetooth technology, transmitted to a smartphone or tablet. A HeartBeat application, called MediBeat, on the smartphone or tablet then transmits the PPG to a server where a proprietary algorithm analyzes the baseline measurement for the person and the PPG to calculate the person's current blood pressure.
Heartbeat's intent is that the current blood pressure reading would then be made available to both the client and the health provider through separate web-based interfaces. Providers would be able to log onto the HeartBeat web-based application from anywhere to review and monitor the blood pressure of multiple clients, while clients can log onto the application to track their own measurements.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Low Blood Pressure, Blood Pressure, High Blood Pressure, Hypertension, Hypotension
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Non-Randomized
Enrollment
94 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Low Blood Pressure
Arm Type
Other
Arm Description
Low blood pressure (systolic: 0-129, diastolic: 0-79)
Arm Title
Medium Blood Pressure
Arm Type
Other
Arm Description
Medium blood pressure (systolic: 130-160, diastolic: 80-100)
Arm Title
High Blood Pressure
Arm Type
Other
Arm Description
High blood pressure (systolic: 161 or higher, diastolic: 101 or higher)
Intervention Type
Device
Intervention Name(s)
Contec CMS50EW
Intervention Description
Participants' blood pressure will be measured 3 times with the wearable finger pulse oximeter at their study visit.
Intervention Type
Device
Intervention Name(s)
Sphygmomanometer
Intervention Description
Participants' blood pressure will be measured 4 times manually with a blood pressure cuff at their study visit.
Primary Outcome Measure Information:
Title
Difference Between Systolic Manual Sphygmomanometer and Finger Pulse Oximeter Readings
Description
Each device reading was compared to the manual blood pressure reading taken before (R1) and after it (R2). The degree of alignment for systolic blood pressure was calculated by taking the difference between the two scores (manual and device). The reading with the best alignment was used.
Time Frame
45 - 60 minutes
Title
Difference Between Diastolic Manual and Device Blood Pressure Readings
Description
Each device reading was compared to the manual reading before (R1) and after (R2) it, to calculate the degree of alignment. The difference of the device and R1, and the device and R2 were taken. The smaller number was used for results reporting.
Time Frame
45-60 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
adult over 25 years of age
Exclusion Criteria:
those who have heart arrhythmias,
atrial fibrillations or atrial flutters,
an inaudible Korotkoff sound,
wounds of the upper arms/wrists, missing fingers, and/or
an arm circumference of more than 55 cm will be excluded
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paul Holyoke, PhD
Organizational Affiliation
SE Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
SE Health
City
Markham
State/Province
Ontario
ZIP/Postal Code
L3R 6H3
Country
Canada
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
33890856
Citation
Holyoke P, Yogaratnam K, Kalles E. Web-Based Smartphone Algorithm for Calculating Blood Pressure From Photoplethysmography Remotely in a General Adult Population: Validation Study. J Med Internet Res. 2021 Apr 23;23(4):e19187. doi: 10.2196/19187.
Results Reference
derived
Learn more about this trial
MediBeat - HeartBeat Observation Trial
We'll reach out to this number within 24 hrs